AVITA Medical, Inc. RCEL

Set alert

Price alert · RCEL

All alert types
15.98 USD +0.57 +3.72%

As of Nov 3, 1:38 PM ET

Bid
15.97 × 2
Ask
16.03 × 2
15.05 Day range 16.61
3.22 52-week range 16.90
YTD
+363.30%
1 year
+322.86%
Open
15.24
Prev close
15.41
Mkt cap
494.33M
Vol
254.00K
Avg vol
495.94K
EPS
-1.43
P/E
0.00
Div yield
0.00%
More statistics
Low
15.05
High
16.61
Forward P/E
-14.33
Beta
1.54
Short ratio
10.24
Inst. own
23.45%
Dividend
0.00
Ex-div date
50-d avg
11.87
200-d avg
10.61
1y target
16.81

5m chart

Chart tools
Interval

Built from the cached five-day intraday bars.

Signals (99)
NameTimeAgo
MACD: Sell SignalNov 3, 11:30 AM2 hours ago
RSI: OverboughtNov 3, 10:55 AM2 hours ago
SMA: BullishNov 3, 10:35 AM3 hours ago
SMA: BearishNov 3, 10:30 AM3 hours ago
RSI: OverboughtNov 3, 10:05 AM3 hours ago
MACD: Buy SignalNov 3, 9:50 AM3 hours ago
RSI: OverboughtNov 3, 9:50 AM3 hours ago
SMA: BullishNov 3, 9:40 AM3 hours ago
MACD: Sell SignalNov 3, 9:30 AM4 hours ago
SMA: BearishNov 2, 3:55 PM21 hours ago
RSI: OverboughtNov 2, 3:15 PM22 hours ago
SMA: BullishNov 2, 2:10 PM23 hours ago
MACD: Buy SignalNov 2, 2:10 PM23 hours ago
SMA: BullishNov 2, 1:50 PM23 hours ago
SMA: BearishNov 2, 1:25 PM1 day ago
MACD: Sell SignalNov 2, 1:25 PM1 day ago
SMA: BearishNov 2, 12:55 PM1 day ago
SMA: BullishNov 2, 12:50 PM1 day ago
SMA: BullishNov 2, 12:50 PM1 day ago
SMA: BearishNov 2, 12:45 PM1 day ago

Newest 20 of 99.

Analyst view

Consensus: buy

Buy
Price target (mean) 16.81 +5.2% upside
Target (low)
11.38
Target (mean)
16.81
Target (high)
20.95
Ratings (0m) 5 3 buy · 2 hold · 0 sell
  • Strong buy0
  • Buy3
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RCEL analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.56534-0.703 – -0.304-0.42801-32.1%35.67M+64.4%6
Next quarter-0.70833-1.26 – -0.272-1.11+35.9%34.14M+103.1%3
Current year-3.28-3.82 – -2.23-2.14-53.3%106.10M+38.4%7
Next year-1.28-2.72 – -0.09097-3.28+61.1%161.14M+51.9%7

Upgrades and downgrades

The latest rating changes

RCEL analyst upgrades and downgrades
DateFirmActionFromTo
Nov 8, 2024Piper SandlerReiteratedNeutralNeutral
Aug 9, 2024Cantor FitzgeraldReiteratedOverweightOverweight
May 14, 2024Piper SandlerDowngradeOverweightNeutral
May 14, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Apr 11, 2024BTIGDowngradeBuyNeutral
Feb 23, 2024Piper SandlerReiteratedOverweightOverweight
Feb 23, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Jan 19, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Nov 21, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Nov 10, 2023Piper SandlerMaintainedOverweightOverweight
Oct 19, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Sep 26, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 22, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 11, 2023Piper SandlerMaintainedOverweightOverweight
Jul 28, 2023B of A SecuritiesMaintainedBuyBuy
Jul 13, 2023Lake StreetMaintainedBuyBuy
Jun 27, 2023Cantor FitzgeraldInitiated—Overweight
Jun 26, 2023Lake StreetMaintainedBuyBuy
Jun 9, 2023Lake StreetMaintainedBuyBuy
May 12, 2023Lake StreetMaintainedBuyBuy
May 12, 2023Piper SandlerMaintainedOverweightOverweight
Apr 17, 2023BTIGMaintained—Buy
Feb 24, 2023Lake StreetMaintainedBuyBuy
Mar 2, 2021Piper SandlerInitiated—Overweight
Aug 27, 2020B of A SecuritiesInitiated—Buy
Jul 9, 2020BTIGMaintained—Buy